论文部分内容阅读
To determine whether risk factors for cardiovascular disease and diabetic nephropathy, as evidenced by abnormalities of ambulatory blood pressure (ABP), dyslipidemia, and microalbuminuria (MA), are present in adolescents with type 2 diabetes mellitus (T2DM). Study design: We enrolled 26 minority adolescents recently diagnosed with T2DM and 13 obese control subjects without diabetes mellitus. ABP monitoring was performed, and a 24- hour urine, a fasting lipid profile, blood urea nitrogen, creatinine, homocysteine, and hemoglobin A1c levels were obtained. The patients with T2DM underwent echocardiograms. Results: Forty percent of the patients with T2DM had MA (≥ 30 mg of microalbumin/day), compared with none of the control subjects (P < .05). There were no significant differences between patients with T2DM who had MA and patients with T2DM who didn’t have MA in demographics, characteristics, casual BP, echocardiographic findings, and hemoglobinA1c levels. Average daytime systolic BP was greater in patients with T2DM with MA than patients without MA (129 versus 121 mmHg, P = .03) and compared with the control subjects (113 mm Hg, P = .01). Patients with MA had an average daytime systolic BP load that was higher than patients without MA(37.1 versus 5.1% , P=.008) and compared with the control subjects (2.6% , P < .001). Conclusion: As in adults, adolescents with T2DM exhibit abnormalities of ABP, dyslipidemia, and microalbuminuria.
To determine whether risk factors for cardiovascular disease and diabetic nephropathy, as evidenced by abnormalities of ambulatory blood pressure (ABP), dyslipidemia, and microalbuminuria (MA), are present in adolescents with type 2 diabetes mellitus (T2DM). Study design: We enrolled ABP monitoring was performed, and a 24-hour urine, a fasting lipid profile, blood urea nitrogen, creatinine, homocysteine, and hemoglobin A1c levels were obtained. The patients with T2DM underwent echocardiograms. Results: Forty percent of the patients with T2DM had MA (≥ 30 mg of microalbumin / day), compared with none of the control subjects (P <.05). There were no significant differences between patients with T2DM who had MA and patients with T2DM who did not have MA in demographics, characteristics, casual BP, echocardiographic findings, and hemoglobinA1c levels. Average daytime systolic BP wa s greater in patients with T2DM with MA than patients without MA (129 versus 121 mmHg, P = .03) and compared with the control subjects (113 mm Hg, P = .01). Patients with MA had an average daytime systolic BP load that was higher than patients without MA (37.1 versus 5.1%, P = .008) and compared with the control subjects (2.6%, P <.001). Conclusion: As in adults, adolescents with T2DM exhibit abnormalities of ABP, dyslipidemia, and microalbuminuria.